ArticleActa orthopaedica2025

Editorial: Why the randomized controlled trial is still at the apex and the gold standard for evaluating new medical and surgical interventions.

Aleksi Reito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.